Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer

THOUSAND OAKS, Calif., May 16, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Web-Based Self-Help Intervention Beneficial for Binge Eating Disorder

THURSDAY, May 16, 2024 -- For patients with binge eating disorder (BED), a web-based cognitive behavioral self-help intervention leads to significant...

2015 to 2021 Saw Increase in Electronic Vaping Product Use in Teens

THURSDAY, May 16, 2024 -- From 2015 to 2021, there were significant increases in the use of electronic vapor products (EVPs) among adolescents, according to a...

Semaglutide Reduces Need for Diuretics in Heart Failure

THURSDAY, May 16, 2024 -- Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in...

Slight Decline Seen in U.S. Drug Overdose Deaths

THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the...

Salmonella Risk Prompts Recall of Cream Cheese From ALDI, Hy-Vee Stores

THURSDAY, May 16, 2024 -- Due to a potential risk for Salmonella, the supermarket chains ALDI and Hy-Vee are recalling brands of cream cheese.No actual...

Spread of Deadlier Mpox Strain in Africa Has CDC Concerned

THURSDAY, May 16, 2024 -- The central African nation of the Democratic Republic of Congo (DRC) is battling a record number of cases of mpox, fueled by a strain...

Plant-Based Diets Lower Risk of Heart Trouble, Cancer and Death

THURSDAY, May 16, 2024 -- Following a vegetarian or vegan diet might just buy you a longer, healthier life, a new review finds. Staying away from meat was...

Brain Decline, Dementia Common Among Older American Indians

THURSDAY, May 16, 2024 -- Higher rates of blood vessel-damaging conditions like hypertension or diabetes may be driving up rates of cognitive decline and...

Dreams Might Help You Process Bad Experiences

THURSDAY, May 16, 2024 -- A good night’s sleep helps clear the cobwebs from your mind, and researchers now think they’ve figured out how dreaming...

Cream Cheese From Aldi, Hy-Vee Stores Recalled Due to Salmonella Risk

THURSDAY, May 16, 2024 -- Two major supermarket chains, Aldi and Hy-Vee, are recalling brands of cream cheese because of a potential risk for salmonella. No...

Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma

PRINCETON, N.J.--(BUSINESS WIRE) May 15, 2024 -- Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted...

Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism

COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA)...

Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication

DEERFIELD, Ill. - 2024-05-13 -- Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded...

FDA Approves Updated Altuviiio Label With Expanded Pediatric Data Confirming Highly Effective Bleed Protection in Children With Hemophilia

Paris, May 10, 2024 -- The US Food and Drug Administration (FDA) has updated the label for Altuviiio® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN...

Select Strengths of Sandoz Biosimilar Hyrimoz Granted Interchangeability by FDA

May 08, 2024 -- On April 5, 2024, the US Food and Drug Administration (FDA) approved Sandoz’s supplemental biologics license application (sBLA) seeking...

Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

DUBLIN, Ireland and CHICAGO, April 29, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company...

Abeona Therapeutics Provides Regulatory Update on Pz-cel

CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...

Supernus Provides Regulatory Update for SPN-830

ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome

NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...

SUPERNOVA Phase III trial of Sipavibart Long-Acting Antibody Met Primary Endpoints in Preventing COVID-19 in Immunocompromised Patient Population

16 May 2024 -- Positive high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial showed AstraZeneca’s...

Elinzanetant Significantly Reduces Frequency and Severity of Moderate to Severe Hot Flashes Associated with Menopause

Berlin, May 16, 2024 – Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, showing that the investigational compound...

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug BIIB105 in Amyotrophic Lateral Sclerosis

CAMBRIDGE, Mass. and CARLSBAD, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc...

Adverse Social Determinants of Health Linked to Treatment-Resistant Hypertension in Black Americans

May 16, 2024 -- People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social...

With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin

INDIANAPOLIS, May 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-2 and QWINT-4 phase 3...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.